Myra Vision

About

Myra Vision, Inc. is a medical technology company founded in 2016 and based in Campbell, California. The company specializes in innovative surgical devices for glaucoma treatment, focusing on reducing intraocular pressure (IOP) and preserving vision in patients with moderate to severe glaucoma. As a portfolio company of Shifamed LLC, Myra Vision is dedicated to personalized glaucoma care, offering adjustable solutions that enhance safety and minimize complications for ophthalmologists. The company's lead product is the Calibreye™ Titratable Glaucoma Therapy™ Surgical System, an investigational adjustable aqueous shunt designed for effective IOP control. This system features four titratable outflow settings for post-surgical adjustments, utilizing materials known for their biocompatibility. Myra Vision has achieved key milestones, including FDA conditional approval for a clinical study and successful initial trials. The company has raised approximately $42 million in funding to support its development efforts.